Closing prices for 09 October 2026
Next earnings report: 04 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Cencora, Inc. trades on NYSE under the ticker COR. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks COR has traded between 244.82 $ and 377.54 $. As of 09 October 2026 the price stood 59.55 % of the way from the 52-week low to the high.
Over one year COR shares rose 4.26 %; over six months they rose 0.94 %. Volatility over 90 days is 26.16 %. Dividends are not included: this is price change only, as of 09 October 2026.
COR trades at a price-to-earnings ratio of 24.5, below the sector median of 24.8. Price to sales is 0.2, below the sector median of 3.9. Price to book is 18.4, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 319.50 | 325.79 | 318.79 | 323.85 | 775,051 |
| 08 October 2026 | 316.59 | 322.58 | 314.90 | 321.35 | 897,600 |
| 07 October 2026 | 317.30 | 322.41 | 315.15 | 317.25 | 1M |
| 06 October 2026 | 314.63 | 316.44 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Cencora distributes medicines to pharmacies and clinics — enormous turnover at a very thin margin, like all three distributors.
A distributor stands between manufacturer and dispensing point and earns fractions of a per cent per pack. At those margins profit is set by logistics: warehouses, routes, inventory turns and forecasting accuracy. An error anywhere consumes the entire margin.
The market is split among three players, which makes it durable: a new entrant cannot build a comparable warehouse network. The higher-margin line is servicing oncology and specialty clinics, where drugs are expensive and storage requirements strict.
A specific factor is opioid litigation settlements, with payments spread over years. Separately significant are high-cost medicines: the shipment value is large while the percentage is unchanged. The company pays a small dividend and buys back stock actively.
Address:1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428, US
Cencora, Inc. reported revenue of 328.7B $ and net income of 2.5B $ over the last four quarters. Net margin is 0.78 %. Revenue changed by +5.95 % year over year. Earnings per share are 13.05 $. Market capitalisation is 62.5B $.
COR has a return on equity of 75.01 %, above the sector median of −41.68 %. Return on assets is 3.12 %, above the sector median of −32.11 %. Operating margin is 0.85 %, above the sector median of −26.84 %.
| 20M |
| NUSNu Skin Enterprises, Inc. | 4.76 | −0.21 % | 2M |
| COSMCosmos Health Inc. | 0.3419 | +8.75 % | 1M |
| HKPDCellyan Biotechnology Co., Ltd | 0.1050 | +4.17 % | 1M |
| ZSTKZeroStack Corp. | 4.62 | −0.43 % | 440,442 |
| 311.83 |
| 316.37 |
| 817,900 |
| 05 October 2026 | 309.43 | 316.06 | 307.87 | 314.93 | 1M |
| 02 October 2026 | 308.29 | 310.43 | 302.14 | 309.05 | 1M |
| 01 October 2026 | 303.18 | 313.02 | 300.77 | 309.78 | 2M |
| 30 September 2026 | 306.40 | 306.40 | 295.01 | 300.25 | 2M |
| 29 September 2026 | 300.00 | 307.62 | 298.21 | 307.60 | 1M |
| 28 September 2026 | 306.20 | 307.94 | 302.84 | 303.81 | 2M |
| 25 September 2026 | 308.95 | 310.89 | 304.31 | 306.92 | 1M |
| 24 September 2026 | 313.32 | 316.61 | 309.18 | 309.87 | 1M |
| 23 September 2026 | 315.51 | 320.24 | 310.71 | 312.28 | 1M |
| 22 September 2026 | 317.62 | 320.00 | 313.89 | 314.43 | 775,700 |
| 21 September 2026 | 309.74 | 316.98 | 308.51 | 316.49 | 1M |
| 18 September 2026 | 307.42 | 311.81 | 304.45 | 308.78 | 3M |
| 17 September 2026 | 318.36 | 319.77 | 309.24 | 309.41 | 1M |
| 16 September 2026 | 321.83 | 323.98 | 317.97 | 318.50 | 931,100 |
| 15 September 2026 | 324.98 | 325.88 | 318.08 | 323.29 | 913,400 |
| 14 September 2026 | 325.64 | 327.79 | 322.46 | 326.23 | 1M |